China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.258
-0.002 (-0.85%)
Nov 4, 2024, 4:00 PM EST - Market closed

China Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
445231910
Upgrade
Market Cap Growth
18.73%-19.49%-78.32%17.59%88.26%-8.00%
Upgrade
Enterprise Value
8813302616
Upgrade
Last Close Price
0.260.604.7924.1322.2911.84
Upgrade
PE Ratio
--0.66-1.27-6.55-6.78-0.50
Upgrade
PS Ratio
0.410.570.612.371.790.94
Upgrade
PB Ratio
0.590.531.153.802.431.12
Upgrade
P/FCF Ratio
15.31-5.61-6.10-33.21-21.3621.85
Upgrade
P/OCF Ratio
13.46-5.70-12.09-91.44-459.7216.96
Upgrade
EV/Sales Ratio
1.241.141.603.102.421.45
Upgrade
EV/EBITDA Ratio
-5.374370.46-15.30131.65259.95-34.06
Upgrade
EV/EBIT Ratio
-1.73-2.91-3.66-10.46-10.20-4.66
Upgrade
EV/FCF Ratio
26.86-11.26-16.00-43.50-28.9233.46
Upgrade
Debt / Equity Ratio
0.550.622.042.080.930.72
Upgrade
Debt / EBITDA Ratio
-58.59-39.1037.57-
Upgrade
Debt / FCF Ratio
14.11-6.52-10.79-18.15-8.1714.02
Upgrade
Asset Turnover
0.420.410.400.440.500.32
Upgrade
Inventory Turnover
2.292.052.552.642.442.18
Upgrade
Quick Ratio
0.220.310.190.530.130.17
Upgrade
Current Ratio
0.840.880.470.860.470.56
Upgrade
Return on Equity (ROE)
-74.89%-52.43%-77.08%-48.49%-33.25%-104.99%
Upgrade
Return on Assets (ROA)
-17.54%-10.04%-10.97%-8.17%-7.43%-6.27%
Upgrade
Return on Capital (ROIC)
-22.27%-13.68%-14.06%-10.54%-10.30%-7.68%
Upgrade
Earnings Yield
-100.04%-77.22%-80.22%-14.88%-14.76%-200.61%
Upgrade
FCF Yield
6.53%-17.84%-16.39%-3.01%-4.68%4.58%
Upgrade
Buyback Yield / Dilution
-609.34%-221.82%-13.96%-5.74%-0.10%-
Upgrade
Total Shareholder Return
-609.34%-221.82%-13.96%-5.74%-0.10%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.